Skip to main content
. 2022 Apr 11;101(7):697–705. doi: 10.1159/000524148

Table 3.

Respiratory SAEs and deaths across LVR-coil treatment and usual care group

LVR-coil treatment (n = 298)
Usual care (n = 229)
RR (95% CI) p value
events patients, n (%) events patients, n (%)
Pneumothorax 31 30 (10) 8 7 (3) 3.3 (1.5–7.4) 0.002
Haemoptysis 6 6 (2) 0 0 (0)
COPD exacerbation 135 92 (31) 69 49 (21) 1.4 (1.1–1.9) 0.01
Pneumonia 69 62 (21) 17 13 (6) 3.7 (2.1–6.5) <0.001
Death 15 15 (5) 16 16 (7) 0.7 (0.4–1.4) 0.34

Data of the ELEVATE were not included because only data on death were available. LVR, lung volume reduction; RR, relative risk; 95% CI, 95% confidence interval.